
    
      A Phase 2, Multicenter, Double-Blinded, Randomized, Vehicle-Controlled Study to Compare the
      Safety and Efficacy of IDP-118 Lotion with Tazorac (tazarotene) Cream, 0.05% in the Treatment
      of Plaque Psoriasis
    
  